is in compliance with cancer surgery principles, despite resulting in a functional deficit and social stigmata and failing to extend survival, especially in cases caught early. Conservative approaches have been used for in situ or minimally invasive cases (Breslow #0.05 mm), providing good aesthetic and functional results. Because of its rarity, there are only a few studies focused specifically on nail melanoma management. We report our experience regarding its prognosis, highlighting the approach. We conducted a retrospective study including 21 patients who sought treatment at Hospital do Servidor P ublico Municipal de São Paulo or a private clinic during 2003-2013. A 2-year follow-up period was considered a part of the inclusion criteria to avoid the loss of cases in the sample. The following were analyzed: patient sex and age; tumor characteristics (anatomic site, invasion level, presence of mitosis, ulceration or regression upon histopathologic exam, and sentinel lymph node impairment); surgical technique used; follow-up length of time after surgery; and outcome (without evidence of disease, local relapse, metastasis, and death) (Table I) .
Regarding the extension of tumor invasion, 13 cases were in situ, 1 case measured 0.31 mm, and 7 ranged 1.9-12 mm. Amputation was performed in 9 cases, while the remaining 12 were treated with local excision and phalangeal preservation (called functional surgery). Visible tumor was removed, like nail bed and matrix in block, which was excised to the bone with a lateral margin of safety of 5 mm, and wound healing was by secondary intention.
As for the outcomes, 2 of 12 patients going through functional surgery locally relapsed, after 11 and 77 months. One had melanoma in situ and was readdressed using the same technique, and the other patient went through amputation because the tumor was invasive. Both of them have no signs of disease at 4 and 5 years of follow-up, respectively. Another patient treated with functional surgery had metastasis into an inguinal lymph node 18 months after the surgery and is now on treatment. Two amputated patients also had metastases: 1 into a mediastinal lymph node 24 months later and is undergoing treatment and the other had lung metastasis 26 months after surgery and died 2 months later.
Variables such as sex, lesion site, thickness (Breslow index), ulceration, mitosis, and the selected surgical technique did not show statistically significant impact on survival (Fig 1) .
Our study confirms other reports in the literature that concluded that the surgical approach does not affect the prognosis of nail melanoma. [3] [4] [5] Although the literature shows that histologic characteristics such as tumor thickness, 4,5 presence of mitosis, and ulceration are prognostic factors for nail melanoma, this was not seen in our data. It is possible that the small sample size reported herein precluded replicating these findings. Cross-sectional assessment of ultraviolet radiationerelated behaviors among young people after a diagnosis of melanoma or basal cell carcinoma
To the Editor: With recent increases in incidence rates of melanoma and nonmelanoma skin cancer (NMSC), especially in young people, skin cancer is important in survivorship research. Risk of multiple skin cancers may be associated with ultraviolet (UV) radiationerelated behaviors after a sentinel skin cancer. 1 Those in whom the disease is diagnosed at a young age have many at-risk years ahead and potentially higher genetic susceptibility. Though data on risk of a second skin cancer from UV is limited, 1 study found that patients with melanoma could reduce further melanoma risk by decreasing recreational sun exposure at any age. 2 A 2015 review found that melanoma survivors reported insufficient levels of sun protection. 3 A recent study of melanoma survivors who were 25 to 59 years of age at diagnosis, found that survivors had healthier behaviors than controls, but these were still suboptimal. 4 Protection behaviors, as well as outdoor and indoor tanning, among individuals with NMSC and younger patients with skin cancer are less well described. Therefore, we conducted an online survey of UV-related behaviors in young skin cancer survivors and evaluated predictors of engaging in these behaviors.
We enrolled individuals who, in the previous 1 to 5 years, had received a diagnosis of basal cell carcinoma (BCC) before age 40 or a diagnosis of stage I or II melanoma before age 50, spoke English, were non-Hispanic white, resided in Connecticut, and had Internet access. Yale University's institutional review board approved the study, and participants provided informed consent. Patients with BCC were recruited from a case-control study of early-onset BCC, 5 and 99 patients enrolled (response rate, 76.2%). We identified 268 patients with melanoma meeting our diagnosis criteria through the YaleeNew Haven Hospital Tumor Registry. A total of 135 patients with melanoma enrolled (response rate, 63.1%); 23 individuals who were ineligible were removed and 31 patients were unreachable. We calculated univariate differences by cancer type and evaluated independent predictors of the behaviors with multivariate logistic regression using SAS software (version 9.3, SAS Institute, Inc, Cary, NC).
One quarter of these patients with skin cancer (26.9%) reported sunbathing after diagnosis (Table I) . 
